Mackay Shields LLC’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Mackay Shields LLC's IDXX Position: Q2 2022 in Review
Mackay Shields LLC sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 12,153 shares — an estimated $6.65M sold.
Mackay Shields LLC first reported a position in IDXX in Q1 2018 and held it in 17 quarters. The position peaked at $15.7M in Q4 2020. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.
- Mackay Shields LLC reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
- Mackay Shields LLC sold 12,153 Idexx Laboratories shares in Q2 2022, an estimated $6.65M.
- Mackay Shields LLC first reported a position in Idexx Laboratories in Q1 2018 and held it in 17 quarters.
- Mackay Shields LLC's Idexx Laboratories position peaked at $15.7M in Q4 2020.
- 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.
Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.